BioAge Labs

About:

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

Website: https://bioagelabs.com

Twitter/X: bioagelabs

Top Investors: Khosla Ventures, OrbiMed, RA Capital Management, Bossanova Investimentos, Andreessen Horowitz

Description:

BIOAGE discovers and develops drugs to treat aging and associated diseases. The company's primary initiative, azelaprag, is an oral APJ agonist on track for Phase 2 trials in conjunction with tirzepatide to potentially become a groundbreaking treatment for obesity in the elderly.